Children with hematologic malignancies continue to exhibit increased IPD risk despite an overall decline in pediatric IPD after the introduction of the PCV13 vaccine.

The introduction of immune checkpoint inhibitors is linked to growing disparity for those with private insurance vs those without insurance.

Topline data were announced from two phase 3 trials evaluating astegolimab in patients with moderate to very severe COPD.

The new guidance on vaccines, such as those that protect against COVID-19, influenza, and RSV, will be released by the end of the summer, ahead of respiratory season.

Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.

Cannabidiol within the range consumers are taking with unregulated products is linked to an increase in liver enzymes.

Radiation can induce amphiregulin expression in tumor cells, increasing their size and shortening patient survival.

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.

The FDA has escalated its recall to reflect a "reasonable probability" that consuming the spread could cause serious illness or death.

Early-onset neonatal infections including sepsis and meningitis are associated with an increased risk of childhood epilepsy.

The prevalence of long COVID-typical symptom clusters was relatively high among a cohort of adults 2 years after initial COVID-19 infection.

Robotic assisted bronchoscopy is noninferior to electromagnetic navigational bronchoscopy for evaluating peripheral pulmonary lesions.